Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling

Journal of Genetic Counseling - Tập 26 Số 4 - Trang 859-865 - 2017
Sommer Hayden1, Sarah Mange2, Debra Duquette2, Nancie Petrucelli3, Victoria M. Raymond4
1Saint Joseph Mercy Hospital, Ann Arbor, MI, USA
2Michigan Department of Health and Human Services Lansing MI USA
3Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA
4University of Michigan Health System, 300 North Ingalls, NI3 A08, Ann Arbor, MI, 48109-5419 USA

Tóm tắt

AbstractGenetic counseling (GC) and genetic testing (GT) identifies high‐risk individuals who benefit from enhanced medical management. Not all individuals undergo GT following GC and understanding the reasons why can impact clinical efficiency, reduce GT costs through appropriate identification of high‐risk individuals, and demonstrate the value of pre‐GT GC. A collaborative project sponsored by the Michigan Department of Health and Human Services prospectively collects anonymous data on BRCA‐related GC visits performed by providers in Michigan, including demographics, patient/family cancer history, GT results, and reasons for declining GT. From 2008 to 2012, 10,726 patients underwent GC; 3476 (32.4%) did not pursue GT. Primary reasons included: not the best test candidate (28.1%), not clinically indicated (23.3%), and insurance/out of pocket cost concerns (13.6%). Patient disinterest was the primary reason for declining in 17.1%. Insurance/out of pocket cost concerns were the primary reason for not testing in 13.4% of untested individuals with private insurance. Among untested individuals with breast and/or ovarian cancer, 22.5% reported insurance/out of pocket cost concerns as the primary reason for not testing and 6.6% failed to meet Medicare criteria. In a five‐year time period, nearly one‐third of patients who underwent BRCA GC did not pursue GT. GT was not indicated in almost half of patients. Insurance/out of pocket cost concerns continue to be barriers.

Từ khóa


Tài liệu tham khảo

10.7326/0003-4819-143-5-200509060-00011

10.1038/gim.2015.41

Armstrong K., 2000, Factors associated with decisions about clinical BRCA1/2 testing, Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 9, 1251

10.1038/gim.2013.181

10.1200/JCO.2006.09.1066

10.1200/JCO.2005.03.6772

10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z

10.1038/ncponc0384

10.1089/gte.2006.9998

10.1200/JCO.1999.17.5.1595

10.1007/s10897-005-0384-3

10.1056/NEJM199901143400201

10.1093/jnci/93.21.1633

10.1089/gte.2006.9999

10.1126/science.1088759

Lee J.(2013).Cigna requires genetic counseling to end inappropriate testing.Modern Healthcare. Retrieved fromhttp://www.modernhealthcare.com/article/20130727/MAGAZINE/307279986

10.1016/j.amepre.2014.01.002

10.1002/ajmg.a.36453

10.1016/j.amjsurg.2009.07.003

10.1002/cncr.21536

10.1093/jnci/djn442

10.1158/1055-9965.EPI-05-0002

10.3322/canjclin.57.2.75

Thompson H. S., 2002, Psychosocial predictors of BRCA counseling and testing decisions among urban African‐American women, Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 11, 1579

Thông tin
Thông tin xuất bản

Journal of Genetic Counseling

Tập 26 Số 4

859-865

Thông tin tác giả